pyruvic acid has been researched along with Glucose Intolerance in 11 studies
Pyruvic Acid: An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
pyruvic acid : A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
Glucose Intolerance: A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Such non-monotonic dose-response effects of iAs on glucose tolerance shed light on the complex interactions between iAs and the systemic glucose metabolism, which could potentially help reconcile some of the conflicting results in human epidemiological studies." | 1.51 | Non-monotonic dose-response effects of arsenic on glucose metabolism. ( Ding, G; Gong, Y; Li, X; Liu, J; Qian, J; Qian, S; Sun, Z; Xue, Y; Zhou, W; Zhuang, Z, 2019) |
| "We find that rapamycin treatment leads to glucose intolerance in both young and old HET3 mice, but in contrast to the previously reported effect of injected rapamycin in C57BL/6 mice, HET3 mice treated with dietary rapamycin responded normally in an insulin tolerance test." | 1.39 | Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive. ( Astle, CM; Baur, JA; Harrison, DE; Lamming, DW; Sabatini, DM; Ye, L, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraki, N | 1 |
| Tanaka, TD | 1 |
| Yoshimura, M | 1 |
| McMurphy, T | 1 |
| Huang, W | 1 |
| Queen, NJ | 1 |
| Ali, S | 1 |
| Widstrom, KJ | 1 |
| Liu, X | 1 |
| Xiao, R | 1 |
| Siu, JJ | 1 |
| Cao, L | 1 |
| Gong, Y | 1 |
| Liu, J | 1 |
| Xue, Y | 1 |
| Zhuang, Z | 1 |
| Qian, S | 1 |
| Zhou, W | 1 |
| Li, X | 1 |
| Qian, J | 1 |
| Ding, G | 1 |
| Sun, Z | 1 |
| Lamming, DW | 1 |
| Ye, L | 1 |
| Astle, CM | 1 |
| Baur, JA | 1 |
| Sabatini, DM | 1 |
| Harrison, DE | 1 |
| Van Sinderen, ML | 1 |
| Steinberg, GR | 1 |
| Jørgensen, SB | 1 |
| To, SQ | 1 |
| Knower, KC | 1 |
| Clyne, CD | 1 |
| Honeyman, J | 1 |
| Chow, JD | 1 |
| Herridge, KA | 1 |
| Jones, ME | 1 |
| Simpson, ER | 1 |
| Boon, WC | 1 |
| Cavalcanti, DM | 1 |
| Castro, LM | 1 |
| Rosa Neto, JC | 1 |
| Seelaender, M | 1 |
| Neves, RX | 1 |
| Oliveira, V | 1 |
| Forti, FL | 1 |
| Iwai, LK | 1 |
| Gozzo, FC | 1 |
| Todiras, M | 1 |
| Schadock, I | 1 |
| Barros, CC | 1 |
| Bader, M | 1 |
| Ferro, ES | 1 |
| Schindler, CE | 1 |
| Partap, U | 1 |
| Patchen, BK | 1 |
| Swoap, SJ | 1 |
| Zhou, J | 1 |
| Xu, G | 1 |
| Bai, Z | 1 |
| Li, K | 1 |
| Yan, J | 1 |
| Li, F | 1 |
| Ma, S | 1 |
| Xu, H | 1 |
| Huang, K | 1 |
| Visinoni, S | 1 |
| Fam, BC | 1 |
| Blair, A | 1 |
| Rantzau, C | 1 |
| Lamont, BJ | 1 |
| Bouwman, R | 1 |
| Watt, MJ | 1 |
| Proietto, J | 1 |
| Favaloro, JM | 1 |
| Andrikopoulos, S | 1 |
| Pradat, PF | 1 |
| Bruneteau, G | 1 |
| Gordon, PH | 1 |
| Dupuis, L | 1 |
| Bonnefont-Rousselot, D | 1 |
| Simon, D | 1 |
| Salachas, F | 1 |
| Corcia, P | 1 |
| Frochot, V | 1 |
| Lacorte, JM | 1 |
| Jardel, C | 1 |
| Coussieu, C | 1 |
| Le Forestier, N | 1 |
| Lacomblez, L | 1 |
| Loeffler, JP | 1 |
| Meininger, V | 1 |
| Yao, XH | 1 |
| Chen, L | 1 |
| Nyomba, BL | 1 |
11 other studies available for pyruvic acid and Glucose Intolerance
| Article | Year |
|---|---|
A Man With Left Ventricular Hypertrophy.
Topics: Adult; Atrophy; Cardiomyopathies; Cerebellar Diseases; Cognitive Dysfunction; Echocardiography; Gluc | 2022 |
Implementation of environmental enrichment after middle age promotes healthy aging.
Topics: Adipose Tissue; Aging; Animals; Behavior, Animal; Body Temperature; DNA, Mitochondrial; Female; Gluc | 2018 |
Non-monotonic dose-response effects of arsenic on glucose metabolism.
Topics: Amino Acids; Animals; Arsenic; Dose-Response Relationship, Drug; Fatty Acids; Glucose; Glucose Clamp | 2019 |
Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive.
Topics: Age Factors; Animals; Blood Glucose; Diet; Female; Genetic Heterogeneity; Genotype; Glucose; Glucose | 2013 |
Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse.
Topics: Adiponectin; Adipose Tissue; Animals; Aromatase; Blood Glucose; Body Weight; Estrogens; Gluconeogene | 2014 |
Neurolysin knockout mice generation and initial phenotype characterization.
Topics: Adipose Tissue; Animals; Blood Glucose; Blood Pressure; Genotype; Gluconeogenesis; Glucose Intoleran | 2014 |
Chronic rapamycin treatment causes diabetes in male mice.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus; Estradiol; Estrogen Replacement The | 2014 |
Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Fasting; Gene E | 2015 |
Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver.
Topics: Animals; Blood Glucose; Body Weight; Dietary Fats; Eating; Fructose-Bisphosphatase; Gene Expression; | 2008 |
Impaired glucose tolerance in patients with amyotrophic lateral sclerosis.
Topics: Adiponectin; Adolescent; Adult; Aged; Amyotrophic Lateral Sclerosis; Blood Glucose; Fatty Acids, Non | 2010 |
Adult rats prenatally exposed to ethanol have increased gluconeogenesis and impaired insulin response of hepatic gluconeogenic genes.
Topics: Age Factors; Animals; Blood Glucose; Central Nervous System Depressants; Diabetes Mellitus, Type 2; | 2006 |